425: Strive CRO Reposts Merger Update with Semler Scientific

Strive's Chief Risk Officer, Jeff Walton, reposted a communication on X.com concerning the proposed business combination with Semler Scientific, Inc.

Summary

• Strive, Inc. and Semler Scientific, Inc. are pursuing a proposed business combination.
• The communication was reposted on X.com by Jeff Walton, Chief Risk Officer of Strive, Inc., on October 2, 2025.
• The filing includes a cautionary statement regarding forward-looking statements related to the proposed transaction, its strategic and financial benefits, timing, and integration.
• Investors are urged to read the Registration Statement on Form S-4, which will include an Information Statement/Proxy Statement/Prospectus, for important information about the proposed transaction.
• Information about participants in the solicitation of proxies from Semler Scientific stockholders will be included in the Information Statement/Proxy Statement/Prospectus.

Sentiment

Score: 5

Explanation: The filing is a standard cautionary statement for a proposed merger, outlining potential benefits but heavily detailing numerous risks and uncertainties, leading to a neutral-to-cautious sentiment.

Positives

• The proposed transaction is expected to yield strategic and financial benefits for the combined company.
• Anticipated cost savings and strategic gains are expected from the business combination.

Risks

• The occurrence of any event, change, or circumstance that could give rise to the right of one or both companies to terminate the merger agreement.
• The possibility that the proposed transaction does not close when expected or at all because conditions to closing are not received or satisfied on a timely basis or at all.
• The outcome of any legal proceedings that may be instituted against Strive, Semler Scientific, or the combined company.
• The possibility that anticipated benefits of the proposed transaction, including cost savings and strategic gains, are not realized when expected or at all.
• Risks associated with the implementation of Bitcoin treasury strategies and other digital assets.
• General economic and market conditions, interest and exchange rates, monetary policy, and laws and regulations and their enforcement could impact anticipated benefits.
• The integration of the two companies may be more difficult, time-consuming, or costly than expected.
• The proposed transaction may be more expensive or take longer to complete than anticipated due to unexpected factors or events.
• Diversion of management's attention from ongoing business operations and opportunities.
• Dilution caused by Strive's issuance of additional shares of its Class A common stock in connection with the proposed transaction.
• Potential adverse reactions of Strive's or Semler Scientific's customers or changes to business or employee relationships resulting from the announcement or completion of the transaction.
• Changes in Strive's or Semler Scientific's share price before closing.
• Other unknown or unpredictable factors could harm Strive, Semler Scientific, or the combined company's results.

Future Outlook

Strive and Semler Scientific anticipate a proposed business combination, expecting strategic and financial benefits, including cost savings and successful integration, though these are subject to significant risks and uncertainties as detailed in the cautionary statements.

Management Comments

• Management believes its expectations with respect to forward-looking statements are based upon reasonable assumptions within the bounds of its existing knowledge of its business and operations, though there can be no assurance that actual results will not differ materially from projected future results.

Industry Context

The mention of 'Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets' indicates that one or both companies are either involved in or considering adopting digital asset strategies, aligning with a growing trend among certain innovative companies to integrate cryptocurrencies into their corporate finance or operational models.

Stakeholder Impact

• Shareholders: Potential dilution from Strive's stock issuance; urged to read merger documents for informed voting and investment decisions.
• Customers: Potential adverse reactions or changes to business relationships due to the announcement or completion of the transaction.
• Employees: Potential changes to employee relationships resulting from the announcement or completion of the transaction.

Next Steps

• Strive intends to file a Registration Statement on Form S-4 with the SEC to register the Class A common stock to be issued.
• The Registration Statement will include an Information Statement of Strive, proxy statement of Semler Scientific, and a prospectus of Strive.
• A definitive Information Statement/Proxy Statement/Prospectus will be sent to the stockholders of Semler Scientific to seek their approval of the proposed transaction.
• Investors and stockholders of Semler Scientific are urged to read the Registration Statement and Information Statement/Proxy Statement/Prospectus when they become available.

Key Dates

Recommendation

The filing is a procedural communication regarding a proposed business combination, emphasizing forward-looking statements and a comprehensive list of risks. It lacks specific financial metrics or new operational details that would significantly alter an investment thesis at this stage. A 'hold' recommendation is appropriate as investors await the full Registration Statement on Form S-4 for a more complete understanding of the merger's terms, financial implications, and strategic rationale before making definitive investment decisions.

Keywords

Strive, Semler Scientific, merger, business combination, SEC filing, Form 425, forward-looking statements, corporate governance, Bitcoin treasury, digital assets